Vaulta vs Mira — how do they compare? Vaulta trades at Rp1,110 (market cap Rp1,84T, Rp74,92M 24h volume), while Mira trades at Rp705.54 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Vaulta is far larger — about 8126.1× Mira's market cap, and Vaulta's circulating supply is 1,7B / 2,1B A (80%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Vaulta for 39 Days and Mira for 22 Days on average.
| A | MIRA | |
|---|---|---|
Market Cap | Rp1,84T | Rp226,43M |
Volume (24h) | Rp74,92M | Rp101,47M |
Circulating Supply | 1,7B / 2,1B A (80%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 39 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Vaulta is trading at Rp1,109.26 with a market cap of Rp1.84 trillion, showing a bearish technical signal as moving averages indicate strong selling pressure. The token's circulating supply is 1.7 million out of a max 2.1 million, with an average hold time of 39 days. Recent on-chain activity shows neutral oscillators, but the RSI_6 at 16.19 suggests potential oversold conditions. Support levels are clustered near Rp1,076–Rp1,105, while resistance lies at Rp1,134–Rp1,163.
Overall outlook is cautious due to bearish momentum, but oversold RSI may present a short-term bounce opportunity. Key risks include low liquidity and high volatility. Investors should monitor support breaks below Rp1,076 for further downside, with regulatory uncertainty in crypto markets adding to caution.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Vaulta is a Web3 banking network designed to enable the next generation of decentralized financial services. Built on one of the most reliable Layer 1 infrastructures in the industry, Vaulta offers real-time performance and institutional-grade features. This supports secure, scalable, and composable applications, ranging from consumer payments to Bitcoin-native yield and tokenized assets.
Read more on A →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →